4.0
13. Juni 2022
Aktueller Mitarbeiter
Bristol, England
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Good learning experience as it is one of the biggest oncology, children's and cardiac centre.
Kontras
Hard to progress, no support for training